Antiphospholipid antibodies in practice;Anticorps antiphospholipides en pratique

Revue de Medecine Interne

Volumn 33, Issue 4, 2012, Pages 176-180

  Miyara, M ^a   Diemert, M C ^a   Amoura, Z ^a   Musset, L ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiphospholipid antibody; Antiphospholipid syndrome; Lupus anticoagulant; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MONITORING; DISEASE ASSOCIATION; HUMAN; MEDICAL PRACTICE; SHORT SURVEY; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; LUPUS COAGULATION INHIBITOR; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84858750080     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.09.018     Document Type: Short Survey

References (33)

1. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
2. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
3. Pengo V., Biasiolo A., Pegoraro C., Cucchini U., Noventa F., Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005, 93:1147-1152.
4. Danowski A., Kickler T.S., Petri M. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006, 33:1775-1779.
5. de Groot P.G., Derksen R.H. The importance of measuring anticardiolipin antibodies. J Thromb Haemost 2006, 4:41-43.
6. Neville C., Rauch J., Kassis J., Solymoss S., Joseph L., Belisle P., et al. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies. Rheumatology (Oxford) 2006, 45:1116-1120.
7. Koike T., Bohgaki M., Amengual O., Atsumi T. Antiphospholipid antibodies: lessons from the bench. J Autoimmun 2007, 28:129-133.
8. Falco M., Sorrenti A., Priori R., Luan F.L., Pittoni V., Agresti M.G., et al. Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome. Ann Ital Med Int 1993, 8:171-174.
9. Garcia Monco J.C., Wheeler C.M., Benach J.L., Furie R.A., Lukehart S.A., Stanek G., et al. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci 1993, 117:206-214.
10. Neville C., Rauch J., Kassis J., Chang E.R., Joseph L., Le Comte M., et al. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost 2003, 90:108-115.
11. Schleider M.A., Nachman R.L., Jaffe E.A., Coleman M. A clinical study of the lupus anticoagulant. Blood 1976, 48:499-509.
12. Brandt J.T., Triplett D.A., Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995, 74:1185-1190.
13. Goudemand J., Caron C., De Prost D., Derlon A., Borg J.Y., Sampol J., et al. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Societe Francaise de Biologie Clinique and for the Groupe d'Etudes sur I'Hemostase et la Thrombose. Thromb Haemost 1997, 77:336-342.
14. Arnoux D., Boutiere B., Sanmarco M. Antiphospholipid antibodies: clinical significance and biological diagnosis. Ann Biol Clin (Paris) 2000, 58:557-574.
15. Harris E.N., Gharavi A.E., Boey M.L., Patel B.M., Mackworth-Young C.G., Loizou S., et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2:1211-1214.
16. Loizou S., McCrea J.D., Rudge A.C., Reynolds R., Boyle C.C., Harris E.N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985, 62:738-745.
17. Hunt J.E., McNeil H.P., Morgan G.J., Crameri R.M., Krilis S.A. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992, 1:75-81.
18. Arvieux J., Roussel B., Jacob M.C., Colomb M.G. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods 1991, 143:223-229.
19. Harris N.E., Pierangeli S. What is the " true" antigen for antiphospholipid antibodies?. Lancet 1990, 336:1505.
20. Oosting J.D., Derksen R.H., Hackeng T.M., van Vliet M., Preissner K.T., Bouma B.N., et al. In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation. Thromb Haemost 1991, 66:666-671.
21. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994, 179:457-462.
22. Cabral A.R., Cabiedes J., Alarcon-Segovia D., Sanchez-Guerrero J. Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome. J Autoimmun 1992, 5:787-801.
23. Tajima C., Suzuki Y., Mizushima Y., Ichikawa Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998, 25:1730-1736.
24. Selva-O'Callaghan A., Ordi-Ros J., Monegal-Ferran F., Martinez N., Cortes-Hernandez F., Vilardell-Tarres M. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance. Thromb Haemost 1998, 79:282-285.
25. Fanopoulos D., Teodorescu M.R., Varga J., Teodorescu M. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998, 25:675-680.
26. Sanmarco M. Is testing for antiphosphatidylethanolamine antibodies clinically useful?. Curr Rheumatol Rep 2011, 13:81-85.
27. Sanmarco M. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called " seronegative antiphospholipid syndrome" Autoimmun Rev 2009, 9:90-92.
28. Sanmarco M., Alessi M.C., Harle J.R., Sapin C., Aillaud M.F., Gentile S., et al. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb Haemost 2001, 85:800-805.
29. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., Matsuura E., et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000, 43:1982-1993.
30. Horita T., Ichikawa K., Kataoka H., Yasuda S., Atsumi T., Koike T. Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies. Lupus 2007, 16:509-516.
31. Jaskowski T.D., Wilson A.R., Hill H.R., Branch W.D., Tebo A.E. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?. Clin Chim Acta 2009, 410:19-24.
32. Tincani A., Morozzi G., Afeltra A., Alessandri C., Allegri F., Bistoni O., et al. Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Clin Exp Rheumatol 2007, 25:268-274.
33. Urbanus R.T., de Groot P.G. Antiphospholipid antibodies - we are not quite there yet. Blood Rev 2011, 25:97-106.